ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
Psybio Therapeutics Corp

Psybio Therapeutics Corp (PSYB)

0.01
0.00
(0.00%)
終了 12月26日 6:00AM

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
0.01
買値
0.005
売値
0.005
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
前日終値
0.01
始値
-
時刻
最終取引時間
平均取引量 (3 か月)
-
財務取引量
-
VWAP
-

PSYB 最新ニュース

KCSA Psychedelics Virtual Investor Conference Presentations Now Available for On-Demand Viewing

NEW YORK, April 29, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the April 27th and 28th...

KCSA Psychedelics Virtual Investor Conference Agenda Announced for April 27th & 28th

NEW YORK, April 25, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, in partnership with KCSA Strategic Communications (“KCSA”), today...

PsyBio Therapeutics Increases Intellectual Property Portfolio with Filing of Novel Genetic Optimization Pathways for ...cont

PsyBio Therapeutics Increases Intellectual Property Portfolio with Filing of Novel Genetic Optimization Pathways for Psychedelic Medication Biosynthesis Patent portfolio now includes four pending...

PsyBio Therapeutics Announces Retention of Market Maker

TORONTO, March 04, 2021 (GLOBE NEWSWIRE) -- PsyBio Therapeutics Corp. (TSXV:PSYB) (“PsyBio” or the “Company”), a leader in the field of psychedelic research and drug development, announces that...

PsyBio Therapeutics Initiates Pilot Scale Development of Proprietary Biosynthetic Psilocybin with Global Contract Research, D...

OXFORD, Ohio and COCONUT CREEK, Fla., March 02, 2021 (GLOBE NEWSWIRE) -- PsyBio Therapeutics Corp. (TSXV:PSYB) (“PsyBio” or the “Company”), a leader in the field of psychedelic research and drug...

PsyBio Announces Second Quarter Financial Results of Leo Acquisition Corp.

TORONTO, March 01, 2021 (GLOBE NEWSWIRE) -- PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) (TSXV:PSYB) (“PsyBio”), a biotechnology company developing a new class of drugs intended...

PsyBio Therapeutics Corp. Begins Trading on the TSX Venture Exchange

TORONTO, Feb. 25, 2021 (GLOBE NEWSWIRE) -- PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) (TSXV: PSYB) (the “Company”) is pleased to announce that at the opening of the market...

PsyBio Completes Reverse Take-Over Transaction

Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

PSYB - Frequently Asked Questions (FAQ)

What is the current Psybio Therapeutics share price?
The current share price of Psybio Therapeutics is $ 0.01
What is the 1 year trading range for Psybio Therapeutics share price?
Psybio Therapeutics has traded in the range of $ 0.00 to $ 0.00 during the past year

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
AAAAAuralite Investments Inc
$ 0.265
(0.00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0.04
(0.00%)
0
AAAlba Minerals Ltd
$ 0.03
(0.00%)
0
A.HArmor Minerals Inc
$ 0.30
(0.00%)
0
AArmor Minerals Inc
$ 0.45
(0.00%)
0
AAAAAuralite Investments Inc
$ 0.265
(0.00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0.04
(0.00%)
0
AAAlba Minerals Ltd
$ 0.03
(0.00%)
0
A.HArmor Minerals Inc
$ 0.30
(0.00%)
0
AArmor Minerals Inc
$ 0.45
(0.00%)
0
AAAAAuralite Investments Inc
$ 0.265
(0.00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0.04
(0.00%)
0
AAAlba Minerals Ltd
$ 0.03
(0.00%)
0
A.HArmor Minerals Inc
$ 0.30
(0.00%)
0
AArmor Minerals Inc
$ 0.45
(0.00%)
0